Answers are grounded in this paper and cite their sources.
Reports an unusual case of Pisa syndrome due to anti-IgLON5 disease, suggesting early treatment can enhance recovery.
Pisa syndrome, characterized by lateral flexion of the trunk, is most often associated with neuroleptic use or neurodegenerative disorders such as Parkinson’s disease. Anti-IgLON5 disease is a rare neuroimmunological condition with overlapping features of autoimmunity and tauopathy, manifesting with sleep and cognitive disturbances, bulbar symptoms, and movement disorders. We report a 50-year-old man who presented with progressive lateral trunk flexion, head drop, dysarthria, and choreiform movements. The classic features of antiIgLon 5 disease including sleep and cognitive disturbances were absent.Serum testing confirmed strong positivity for anti-IgLON5 antibodies. Treatment with rituximab led to marked clinical improvement, with marked improvement of symptoms at 24 months. This case illustrates an uncommon presentation of anti-IgLON5 disease as Pisa syndrome . Recognition of this association is important, as early immunotherapy can significantly improve outcomes in an otherwise progressive and disabling condition.
No takes yet. Share an insight, caveat, or question.
Nambiar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: